Search

everythinglearnresearchcommunity

for

Search:↓

Skin reactions from cancer treatments might predict how well the treatments work.

A20 protein is crucial for normal skin and hair development.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

FDG PET/CT scans can change cancer treatment plans for dogs.

Scientists turned mouse stem cells into skin cells that can grow into skin layers and structures.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Nanotechnology shows promise for better chronic wound healing but needs more research.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

No treatment fully prevents hair loss from chemotherapy yet.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Increasing Wnt10b levels can help grow new hair follicles in mice.

50-nm nanoparticles are better at penetrating skin and targeting hair follicles for drug delivery than 100-nm ones.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.